The Bull Case For Pfizer (PFE) Could Change Following New COVID And Lyme Vaccine Milestones - Learn Why

In August 2026, Pfizer and BioNTech received U.S. FDA approval for their updated COMIRNATY COVID-19 vaccine targeting the XFG ...
ad-hoc-news

Comirnaty by Pfizer Inc. - updated mRNA vaccine targets current variants

Comirnaty, the mRNA COVID-19 vaccine from Pfizer, is now offered in updated formulations designed to match circulating Omicron-lineage variants. This product is driving the price of Pfizer Inc ...
Nasdaq

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to ...
RAPS

FDA approves Comirnaty as first COVID vaccine

The US Food and Drug Administration (FDA) has approved Pfizer and BioNTech’s mRNA COVID-19 vaccine, Comirnaty, for people 16 years or older. The announcement represents not just the first ...
ad-hoc-news

Comirnaty COVID-19 vaccine: how Pfizer’s mRNA shot fits today

Comirnaty is an mRNA vaccine that delivers genetic instructions for human cells to produce the SARS-CoV-2 spike protein, training the immune system to recognize and respond to the virus without ...